Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jun 1, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app called the Maya Perinatal Cognitive Behavioral Skills App, designed to help pregnant and postpartum individuals who are dealing with anxiety, depression, or stress. The app has 12 modules that teach useful skills to better manage mood and anxiety during this important time. Participants will use the app and provide feedback through questionnaires and interviews while tracking their daily symptoms. The researchers hope to find that the app is helpful and easy to use, and that those who engage with it more will report feeling less anxious and depressed.
To be eligible for this study, participants must be 18 years or older, currently pregnant or up to 12 months postpartum, and identify as female, trans-male, non-binary, or gender questioning. They should also have access to a smartphone and be comfortable using it for the study. It's important to note that individuals with severe safety concerns, current substance use disorders, or certain mental health conditions will not be able to participate. If you join, you can expect a supportive environment where your thoughts and feelings about the app will be valued, helping researchers understand how to best support others in similar situations.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female, Trans-male, non-binary, gender expansive, or gender questioning gestational carriers of pregnancy
- • Currently pregnant or up to 12 months postpartum
- • 18 years or older
- • English proficiency
- • Have access to a smartphone or other mobile device capable of receiving Short Message Service (SMS) pushes and complete Qualtrics surveys and App modules
- • Be available to speak by phone or secure video-conference platform at points throughout the study.
- Exclusion Criteria:
- • Safety concerns at the time of enrollment, including, but not limited to, a response \>0 on the EPDS question 10 or reported suicidal or self-harm thoughts or behaviors within one year of enrollment
- • Current substance use disorder
- • History of a bipolar or psychotic disorder, or current symptoms of psychosis or mania.
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Andrea Temkin-Yu, Psy.D.
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported